ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981

“Flat” Administrative Structure To Include Resource Teams

September 15, 1995

Breast Treatment Component Will Be Planned for WHI

June 21, 1991

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993